Cargando…

Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A

Novel-antibiotics are urgently needed to combat an increase in morbidity and mortality due to resistant bacteria. The preclinical candidate corallopyronin A (CorA) is a potent antibiotic against Gram-positive and some Gram-negative pathogens for which a solid oral formulation was needed for further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krome, Anna K., Becker, Tim, Kehraus, Stefan, Schiefer, Andrea, Steinebach, Christian, Aden, Tilman, Frohberger, Stefan J., López Mármol, Álvaro, Kapote, Dnyaneshwar, Jansen, Rolf, Chaverra-Muñoz, Lillibeth, Hübner, Marc P., Pfarr, Kenneth, Hesterkamp, Thomas, Stadler, Marc, Gütschow, Michael, König, Gabriele M., Hoerauf, Achim, Wagner, Karl G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698778/ https://www.ncbi.nlm.nih.gov/pubmed/33217948 http://dx.doi.org/10.3390/pharmaceutics12111105

Ejemplares similares

Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections
por: Schiefer, Andrea, et al.
Publicado: (2020)

In Vitro–In Vivo Relationship in Mini-Scale—Enabling Formulations of Corallopyronin A
por: Becker, Tim, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus
por: Rox, Katharina, et al.
Publicado: (2022)

The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus
por: Balansky, Jan, et al.
Publicado: (2022)

Complete Genome Sequence of the Corallopyronin A-Producing Myxobacterium Corallococcus coralloides B035
por: Bouhired, Sarah, et al.
Publicado: (2019)

Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A
por: Edwards, Jennifer L., et al.
Publicado: (2022)

Elaborations on Corallopyronin A as a Novel Treatment Strategy Against Genital Chlamydial Infections
por: Loeper, Nathalie, et al.
Publicado: (2019)

Macrophages Mediate Increased CD8 T Cell Inflammation During Weight Loss in Formerly Obese Mice
por: Surendar, Jayagopi, et al.
Publicado: (2020)

NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae
por: Ajendra, Jesuthas, et al.
Publicado: (2016)

Optimization of the production process for the anticancer lead compound illudin M: process development in stirred tank bioreactors
por: Chaverra-Muñoz, Lillibeth, et al.
Publicado: (2022)

Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils
por: Frohberger, Stefan J., et al.
Publicado: (2019)

Adiponectin Limits IFN-γ and IL-17 Producing CD4 T Cells in Obesity by Restraining Cell Intrinsic Glycolysis
por: Surendar, Jayagopi, et al.
Publicado: (2019)

Optimization of the production process for the anticancer lead compound illudin M: improving titers in shake-flasks
por: Chaverra-Muñoz, Lillibeth, et al.
Publicado: (2022)

Optimization of the production process for the anticancer lead compound illudin M: downstream processing
por: Chaverra-Muñoz, Lillibeth, et al.
Publicado: (2022)

IL-4 receptor dependent expansion of lung CD169(+) macrophages in microfilaria-driven inflammation
por: Fercoq, Frédéric, et al.
Publicado: (2019)

The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration
por: Pfarr, Kenneth M., et al.
Publicado: (2023)

The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use
por: Pfarr, Kenneth M., et al.
Publicado: (2023)

S100A8/S100A9 deficiency increases neutrophil activation and protective immune responses against invading infective L3 larvae of the filarial nematode Litomosoides sigmodontis
por: Frohberger, Stefan J., et al.
Publicado: (2020)

ILC2s Control Microfilaremia During Litomosoides sigmodontis Infection in Rag2(-/-) Mice
por: Reichwald, Julia J., et al.
Publicado: (2022)

Quinolone-fused cyclic sulfonamide as a novel benign antifilarial agent
por: Mukherjee, Suprabhat, et al.
Publicado: (2018)

The Annotated Genome of Wolbachia from the Filarial Nematode Brugia malayi: What It Means for Progress in Antifilarial Medicine
por: Pfarr, Kenneth, et al.
Publicado: (2005)

In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae
por: Hübner, Marc P., et al.
Publicado: (2019)

Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds
por: Hübner, Marc P., et al.
Publicado: (2019)

Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis
por: Ehrens, Alexandra, et al.
Publicado: (2022)

Eosinophils in filarial infections: Inducers of protection or pathology?
por: Ehrens, Alexandra, et al.
Publicado: (2022)

Helminths and their implication in sepsis – a new branch of their immunomodulatory behaviour?
por: Hübner, Marc P, et al.
Publicado: (2013)

Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside
por: Hübner, Marc P., et al.
Publicado: (2021)

AmiD Is a Novel Peptidoglycan Amidase in Wolbachia Endosymbionts of Drosophila melanogaster
por: Wilmes, Miriam, et al.
Publicado: (2017)

Human filariasis—contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model
por: Risch, Frederic, et al.
Publicado: (2021)

A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs
por: Schlabe, Stefan, et al.
Publicado: (2022)

Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro
por: Hübner, Marc P., et al.
Publicado: (2020)

Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode Litomosoides sigmodontis
por: Scheunemann, Johanna F., et al.
Publicado: (2023)

Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model
por: Specht, Sabine, et al.
Publicado: (2018)

Marilones A–C, phthalides from the sponge-derived fungus Stachylidium sp.
por: Almeida, Celso, et al.
Publicado: (2011)

In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis
por: Ehrens, Alexandra, et al.
Publicado: (2020)

Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses
por: Layland, Laura E., et al.
Publicado: (2015)

TGFβ depletion does neither modulate acute E. coli-induced inflammatory immune responses nor impair the protective effect by chronic filarial infection
por: Buerfent, Benedikt C., et al.
Publicado: (2019)

Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis
por: Reiter-Owona, Ingrid, et al.
Publicado: (2015)

Isolation of fungi using the diffusion chamber device FIND technology
por: Libor, Benjamin, et al.
Publicado: (2019)

Drugs for neglected tropical diseases: availability of age-appropriate oral formulations for young children
por: Al-Obaidi, Issraa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7bflrsu307fgdvtvm7qltnb4dj